CARTER TODD ALFRED (Chief Scientific Officer) sold 6.3% of their position (5.41K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $24.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2025ACC: 0001104659-25-012200
Officer· Chief Scientific Officer
Since Feb 2026
-5.41K
Net shares
Net seller
$24.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.41K
Price / share
$4.45
Trade value
$24.09K
% of position
6.3%
2/11/2025
86.44K→81.02K
Total
Net shares
−5.41K
Net value
-$24.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2025 | S · Sale | −5.41K | $4.45 | $24.09K | 6.3% | 86.44K | 81.02K |
| Total | −5.41K | -$24.09K | ||||||
Derivative Transactions0
No derivative transactions reported